Home/Investors/Boehringer Ingelheim Venture Fund

Boehringer Ingelheim Venture Fund

Biotech Investor · 3 portfolio companies

Portfolio

3

Focus Areas

11

Top Stage

Pre-clinical

Investment Focus

Neurodegenerative Diseases Amyotrophic Lateral Sclerosis Frontotemporal Dementia Alzheimer's Disease Parkinson's Disease Huntington's Disease Respiratory Diseases Genetic Disorders Viral Infections Oncology Fibrotic Diseases

Portfolio Companies

Company	Stage	Valuation	Focus
Libra Therapeutics	Pre-clinical	—	Neurodegenerative Diseases, Amyotrophic Lateral Sclerosis
Ethris	Pre-clinical	—	Respiratory Diseases, Genetic Disorders
Actym Therapeutics	Phase 1	—	Oncology, Fibrotic Diseases

Frequent Co-Investors

Dolby Family Ventures1 shared Illumina Ventures1 shared Atlas Venture1 shared Santé Ventures1 shared dievini Hopp BioTech holding1 shared Alta Partners1 shared Epidarex Capital1 shared Yonjin Venture1 shared